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Table 3. OCT ﬁndings of in-stent restenosis between generations of DES
1st generation (n¼54) 2nd generation (n¼32) p
TCFA 18 (33.3%) 4 (12.5%) 0.032
Lipidic neointima 50 (92.6%) 27 (87.1%) 0.404
Calciﬁc neointima 6 (11.1%) 3 (9.4%) 0.799
Thrombi 25 (46.3%) 15 (46.9%) 0.421
Rupture 23 (42.6%) 8 (25.0%) 0.100
Microvessel 30 (55.6%) 17 (53.1%) 0.827
TCFA or Rupture 30 (55.6%) 8 (25.0%) 0.006
ISR pattern 0.104
Homogenous 20 (37.0%) 12 (48%)
Heterogenous 26 (48.1%) 6 (24.0%)
Layered 8 (14.8%) 7 (28.0%)
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expansion being performed ﬁrst, while repeat stenting was reserved
for cases with signiﬁcant intrastent tissue proliferation. Both the
angiogram and the pre-intervention OCT were analyzed separately by
the core lab team. For each case, the core lab would assign a virtual
treatment approach based on the angiogram alone or based on the
OCT alone.
RESULTS 70 cases of late stent thrombosis were analyzed. Based
on OCT, intrastent thrombus was identiﬁed in all the cases.
Excessive tissue proliferation was noted in 27 patients, uncovered /
malapposed struts in 27 patients, both ﬁndings in 14 patients, and
no clear culprit in 2 patients. By angiography, excessive tissue
proliferation was noted in 37 patients, uncovered/malapposed
struts in 19 patients, and no clear culprit in 14 patients. There was
poor agreement between OCT and angiography (kappa 0.11,
p¼0.11). Based on the proposed algorithm, the virtual treatment
strategy was changed by OCT relative to angiography guidance in
32.8% of the cases, with repeat stenting advocated for only 51% of
the cases.
CONCLUSIONS OCT can effectively identify multiple intra-stent pa-
thologies in late stent thrombosis. Information obtained from OCT can
substantially change how PCI is performed when a predeﬁned treat-
ment algorithm is followed.
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BACKGROUND Although in-stent neoatherosclerosis contributes to
late failure of bare metal and ﬁrst generation drug eluting stent (DES),
there is lack of data on new, 2nd generation DES. The aim of this study
was to compare the characteristics of in-stent neoatherosclerosis of
2nd generation DES and 1st generation DES using optical coherence
tomography (OCT).
METHODS Pre-procedural OCT and grayscale intravascular ultra-
sound were analyzed in 86 patients (58 stable angina, 28 acute coro-
nary syndrome) who underwent clinically-driven target lesion
revascularization (TLR) within the 4 years after DES placement. 1st
generation DES group was composed of 16 sirolimus-eluting stents
and 35 paclitaxel-eluting stents; and 2nd generation DES was
composed of 21 everolimus-eluting stents, 9 zotarolimus-eluting
stents, and 2 novolimus-eluting stents.
RESULTS The median duration for target lesion failure were 11.2
months (IQR 5.7-23.6 months) in 1st generation DES and 8.9 months
(IQR 6.1-15.9 months) in 2nd generation DES (p¼0.222). In both gen-
erations, focal stenosis was the predominant type of angiographic
restenosis. Overall, 1st generation DES had more frequent OCT-
deﬁned in-stent thin-cap ﬁbroatheroma (TCFA)–containing neo-
intimal lesions than 2nd generation DES (33.3% vs 12.5%, p¼0.032)
and the signiﬁcance was mainly developed after 12 months of DES
implantation (TLR <12 months after implantation, 15.0% vs 18.2%,
p¼0.818, DES 12 months after implantation, 44.1% vs 9.5%,
p¼0.007). Otherwise there were no differences in other of unstable
neointimal morphology such as the frequency of rupture (42.6% vs.
25.0%, p¼0.100), thrombi (46.3% vs. 46.9%, p¼0.421) or microvessel
(55.6% vs. 53.1%, p¼0.827).
CONCLUSIONS The OCT morphological characteristics of in-stent
neoatherosclerosis between generations of DES were similar. But 2nd
generation DES demonstrated lesser OCT-detected TCFA than 1st
generation DES, especially after 12 months of implantation.CATEGORIES IMAGING: Intravascular
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Early vascular responses to everolimus-eluting cobalt-chromium stent for
the treatment of stable coronary artery disease: The results of
MECHANISM-Elective 1-month OCT follow-up cohort
Toshiro Shinke,1 Hiromasa Otake,1 Daisuke Terashita,2
Tetsuya Fusazaki,3 Tatsuo Kikuchi,4 Takayuki Okamura,5
Takashi Morita,6 Takahiro Sawada,7 Akira Matsuura,8
Yoshinori Yasaka,9 Amane Kozuki,10 Junya Shite,10 Toru Kataoka,11
Kiyoshi Hibi,12 Shozo Ishihara,13 Takashi Akasaka,14 Takashi Kubo,15
Shinjo Sonoda,16 Jungo Furuya,17 Teppei Sugaya,18 Yoshisato Shibata,19
Nehiro Kuriyama,19 Daisuke Matsumoto,20 Yoritaka Otsuka,21
Yoshihiro Morino22
1Kobe University Graduate School of Medicine, Kobe-city, Hyogo;
2Kobe University Graduate School of Medicine, Kobe, Japan; 3Iwate
Medical University, Morioka Iwate, Japan; 4Edogawa Hospital,
Edogawa ku, Tokyo; 5Yamaguchi University Graduate School of
Medicine, Ube, Yamaguchi; 6Osaka General Medical Center, Osaka, AK;
7Himeji Cardiovascular Center, Himeji, Hyogo; 8Akashi Medical Center,
Akashi, GA; 9Himeji cardiovascular Center, Himeji, Hyogo; 10Osaka
Saiseikai Nakatsu Hospital, Osaka, Osaka; 11Bell Land General Hospital,
Sakai, Osaka; 12Yokohama City University Medical Center, Yokohama,
Japan; 13Mimihara General Hospital, Sakai, Osaka; 14Wakayama Medical
University, Wakayama, Japan; 15Wakayama Medical University,
Wakayama, Wakayama; 16University of Occpational and Environmental
Health, Kitakyushu, Japan; 17Hokkaido Social Insurance Hospital,
Sapporo, Hokkaido; 18Hokkaido Social Insurance Hospital, Sapporo,
Japan; 19Miyazaki medical association hospital, Miyazaki, Japan;
20Yodogawa Christian Hospital, Osaka, GA; 21Fukuoka Wajiro Hospital,
Fukuoka, Fukuoka; 22Iwate Medical University, Morioka, Iwate
